The application of tacrolimus administrating via feeding tubes practical scheme in lung transplantations

Optimization and application research of tacrolimus administrating via feeding tubes practical scheme in lung transplantations

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400089199

Enrollment

Unknown

Registered

2024-09-03

Start date

2024-10-01

Completion date

Unknown

Last updated

2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung transplantation

Interventions

Experimental group:Tacrolimus administrating via feeding tubes practical scheme

Control group:The existing conventional administration process of tacrolimus

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Early postoperative patients after lung transplantation; (2) Tacrolimus tube feeding treatment; (3) Over 18 years old; (4) The patient or their family members have informed consent and voluntarily participate.

Exclusion criteria

Exclusion criteria: (1) Recipients who changed their immunosuppressive agents during the study period; (2) Patients with other important diseases, such as severe liver and kidney dysfunction and malignant tumors.

Design outcomes

Primary

Measure	Time frame
Tacrolimus valley concentration;Coefficient of variation of tacrolimus trough concentration;Daily dose of tacrolimus;Coefficient of variation of daily dose of tacrolimus;Standardized blood concentration of tacrolimus;Tacrolimus Valley Concentration Compliance Rate;	—

Secondary

Measure	Time frame
Nurses' medication safety ability;	—

Countries

China

Contacts

Public ContactXuehong Zhao

The First Affiliated Hospital ,Zhejiang University School of Medicine

1192076@zju.edu.cn+86 137 5088 0655

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026